U32 CAR-T
/ Shanghai Unicar
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
New P1/2 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
1 to 1
Of
1
Go to page
1